Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsuedu.ru/handle/123456789/28298
Название: Pharmacogenetic study of lipid-lowering therapy with rosuvastatin in coronary artery disease patients
Авторы: Polonikov, A.
Zvyagina, M.
Krivoshei, I.
Sirotina, S.
Churnosov, M.
Ключевые слова: medicine
medical genetics
genetic polymorphism
coronary artery disease
CAD
lipid-lowering therapy
pharmacology
rosuvastatin
Дата публикации: 2015
Библиографическое описание: Pharmacogenetic study of lipid-lowering therapy with rosuvastatin in coronary artery disease patients / A. Polonikov [et al.] // Annals Academy of Medicine, Singapore. - 2015. - Vol.44, №10, suppl.1.-P. S319. - (Advancing Healthcare Into The Future: Innovate, Improve, Integrate : 6th Singapore Health and Biomedical Congress, Singapore, 2-3 October 2015).
Краткий осмотр (реферат): Polymorphic genes involved in the regulation of lipid metabolism may be responsible for interindividual differences in efficiency of hypolipidaemic therapy. In the present prospective and randomised study, we investigated the efficacy of rosuvastatin (10 mg/day) in lipid-lowering therapy in 62 patients with coronary artery disease (CAD) possessing different genotypes of lipoprotein lipase (LPL) gene
URI (Унифицированный идентификатор ресурса): http://dspace.bsu.edu.ru/handle/123456789/28298
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Sirotina_Pharmacog.pdf18.49 kBAdobe PDFПросмотреть/Открыть
Показать полное описание ресурса Просмотр статистики


Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.